From medicine price control to deregulation: assessing policy effects on insulin access in Pakistan’s private pharmacies
Insulin prices increased significantly following the deregulation policy, particularly for non-NEML OBs, leading to reduced affordability despite fair availability. A policy review and stronger financial protection measures are needed to ensure equitable access to insulin.
Authors
- Amna Saeed (ORCID: https://orcid.org/0000-0002-0284-0260)
- Jinran Zhao
- Minghuan Jiang (ORCID: https://orcid.org/0000-0001-6536-5105)
- Yu Fang
- Najwa Ali Yasin
- Zaheer-Ud-Din Babar
- Caijun Yang
Institutions
- Qatar University (QA)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-03-20
- DOI
- https://doi.org/10.1371/journal.pone.0337151
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00